Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()

Detalles Bibliográficos
Autores principales: Kell, Douglas B, Goodacre, Royston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution 2014
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617745/
https://www.ncbi.nlm.nih.gov/pubmed/28843314
http://dx.doi.org/10.1016/j.drudis.2014.03.019
_version_ 1783267045530402816
author Kell, Douglas B
Goodacre, Royston
author_facet Kell, Douglas B
Goodacre, Royston
author_sort Kell, Douglas B
collection PubMed
description
format Online
Article
Text
id pubmed-5617745
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
record_format MEDLINE/PubMed
spelling pubmed-56177452017-10-11 Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182() Kell, Douglas B Goodacre, Royston Drug Discov Today Corrigendum Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution 2014-11 /pmc/articles/PMC5617745/ /pubmed/28843314 http://dx.doi.org/10.1016/j.drudis.2014.03.019 Text en © 2014 The Authors http://creativecommons.org/licenses/by/3.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Corrigendum
Kell, Douglas B
Goodacre, Royston
Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title_full Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title_fullStr Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title_full_unstemmed Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title_short Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
title_sort corrigendum to “metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [drug discov. today 19 (2014), 171–182()
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617745/
https://www.ncbi.nlm.nih.gov/pubmed/28843314
http://dx.doi.org/10.1016/j.drudis.2014.03.019
work_keys_str_mv AT kelldouglasb corrigendumtometabolomicsandsystemspharmacologywhyandhowtomodelthehumanmetabolicnetworkfordrugdiscoverydrugdiscovtoday192014171182
AT goodacreroyston corrigendumtometabolomicsandsystemspharmacologywhyandhowtomodelthehumanmetabolicnetworkfordrugdiscoverydrugdiscovtoday192014171182

Ejemplares similares